Phluence

What Phluence does

Phluence is a private B2B SaaS company that provides an agentic AI platform for pharmaceutical commercialization, headquartered in San Francisco with 11–50 employees. The company's core offering automates post-prescription patient services workflows for pharmaceutical manufacturers—including benefits investigation, prior authorization, affordability program enrollment, specialty pharmacy fulfillment, field reimbursement management, and gross-to-net optimization—replacing traditional FTE-heavy hub models with always-on software agents. The platform is organized around three integrated layers: an Action Agents library (a catalog of pre-built specialized agents such as Eligibility, Alternate Coverage, Pharmacy, Bridge Conversion, and Benefit Sentinel), an Access Agent that applies tokenization-based temporal intelligence to longitudinal patient data, and a Longitudinal Data layer that integrates electronic health records, pharmacy claims, and patient registries to build per-patient journey views.

The company serves named enterprise pharmaceutical customers including GSK, AstraZeneca, Biogen, Arcutis Biotherapeutics, and Braeburn, selling through direct enterprise field sales with proof-of-concept and ROI-based engagement. Phluence reports quantifiable outcomes including a 10% higher first-fill rate and 18% more time on therapy for patients interacting with its digital assistants versus non-users. The platform is HIPAA, GDPR, UK GDPR, and CCPA compliant, with self-certified alignment to the EU-U.S. Data Privacy Framework. A separate Patient Engagement Platform module and a set of revenue-conversion modules (Bridge Conversion, Benefit Sentinel, Annual Reverification/Reenrollment) extend coverage across the full post-prescription journey.

Phluence has raised approximately $15.75M in disclosed equity funding across rounds from 2017 through 2022, led historically by DigiTx Partners and Primera Capital. In November 2025, Precision AQ made a strategic investment that establishes Precision AQ as a parent entity; Jake Graetz holds dual roles as Phluence CEO and Precision AQ EVP for Strategy, Innovation & Partnerships. The company has no public revenue disclosure, operates primarily in the United States, and distributes its platform through direct enterprise sales with no publicly disclosed pricing or tiered plans.

Name

Phluence

Legal name

Phluence, Inc.

Website

https://phluence.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Phluence is a private B2B SaaS company that provides an agentic AI platform automating post-prescription patient services workflows for pharmaceutical manufacturers, including benefits investigation, prior authorization, affordability programs, and gross-to-net optimization, serving enterprise customers such as GSK, AstraZeneca, Biogen, Arcutis Biotherapeutics, and Braeburn.

Ownership category

akta.pro rank

Product category

Pharmaceutical Commercialization Software

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)

akta.pro secondary industries

EHR/EMR Integration & Interoperability Middleware (HL7/FHIR) (HLALAKAD), Pharmacy Information Systems (PIS) & Dispensing Workflow (HLACAKAC)

Keywords

• Pharmaceutical commercialization
• Patient engagement platform
• Agentic AI workflows
• Market access solutions
• Patient support services

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Platform Licensing/SaaS: Phluence provides an AI-powered workflow platform to pharmaceutical manufacturers on a subscription or licensing basis. The platform is described as a tech-first system that excels at managing complex workflows 24/7 without increasing human footprint of manufacturer operations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Phluence provides an agentic AI-powered workflow platform for pharmaceutical commercialization. The platform combines Action Agents (autonomous AI agents), Access Agent (temporal intelligence for patient-level insights), and Longitudinal Data (patient history from EHRs, pharmacy claims, and registries) to automate patient services operations including benefits verification, prior authorization, enrollment, affordability program eligibility, pharmacy fulfillment, and adherence monitoring. It is sold as a SaaS subscription to pharmaceutical manufacturers for patient engagement, intelligent workflow automation, and revenue optimization.

Product overview

Phluence is an agentic AI-powered workflow platform for pharmaceutical commercialization. The platform consists of a core Phluence Platform built on three integrated layers: Action Agents (a library of pre-built and custom AI agents), Access Agent (temporal intelligence for patient-level insights), and Longitudinal Data (patient data from multiple sources). The platform assembles solutions across three categories: Patient Engagement Solutions (Patient Marketing Agent, Enrollment Agent, Call Center/Contact Center Agent, Consented Patient Pipeline), Intelligent Workflow (Patient Case Management Agent, FRM Automation Agent, HCP Workflow Agent, Market Access Insight Agent), and Revenue Conversion Solutions (Bridge Conversion Agent, Benefit Sentinel, Gross-to-Net Optimization Agent). Phluence also offers a dedicated Patient Engagement Platform covering the full post-prescription journey from brand awareness through care continuity.

Differentiator

Problem solved

Functional benefit

Products and services

• Phluence Platform A data-driven, dynamic healthcare AI platform integrating Action Agents, Access Agent, and Longitudinal Data to execute patient services functions for pharmaceutical manufacturers. Manages complex workflows 24/7 without increasing the human footprint of a manufacturer's patient services operation.
• Patient Engagement Solutions Suite of AI-driven solutions including Patient Marketing Agent, Enrollment Agent, Call Center/Contact Center Agent, and Consented Patient Pipeline for automating patient outreach, enrollment, and ongoing support. Enables proactive engagement via in-EHR and Digital Ad pipeline with Conversational and Voice Assistance.
• Intelligent Workflow Solutions Multiagent workflow automation including Patient Case Management, FRM Automation, HCP Workflow, and Market Access Insight agents for field reimbursement teams, healthcare providers, and patient support teams.
• Revenue Conversion Solutions Solutions including Bridge Conversion, Benefit Sentinel, and Gross-to-Net (GTN) Optimization to prevent revenue leakage, monitor patient benefit carve-outs, address accumulator and maximizer impact, claw back duplicative 340B rebates, and transition patients from temporary bridge programs to permanent coverage.
• Patient Engagement Platform Multi-stage platform guiding patients through the post-prescription journey covering brand offer awareness, benefits investigation, virtual hub enrollment, prior authorization, affordability programs, pharmacy fulfillment, and care continuity.

Quantifiable outcome

• 10% higher first-fill rate for patients who interacted with digital assistant vs non-users
• +1 more outcomes

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature5 records

Scale indicators1 record

Recent moves6 records

Expansion highlights6 records

Direct peers

• Veeva Systems: Veeva provides cloud software for the life sciences industry, including commercial and patient engagement capabilities. It is the dominant horizontal pharma cloud platform that Phluence must compete against or integrate with for pharma manufacturer accounts.
• AssistRx: AssistRx delivers specialty therapy patient access and hub services for pharmaceutical manufacturers, including electronic benefits investigation, prior authorization, and patient enrollment — directly overlapping with Phluence's Patient Engagement and Workflow solutions.
• OptimizeRx: OptimizeRx provides a digital therapeutics activation platform that engages patients and providers at the point of prescription. Its patient engagement and adherence use cases closely parallel Phluence's Patient Marketing and Enrollment Agents.
• Inmar Intelligence: Inmar operates hub services, Alternate Funding Program management, and 340B-related workflows for pharma manufacturers — directly overlapping with Phluence's Benefit Sentinel, AFP, and GTN Optimization modules.
• Sonexus Health: Sonexus Health (part of BPL) provides patient access, hub, and pharmacy services for specialty pharmaceutical manufacturers. It is a direct competitor in the virtualized patient services and bridge conversion space that Phluence targets.

Broad incumbents

• IQVIA: IQVIA is a large CRO and commercialization services provider with patient engagement, market access, and hub services offerings. It overlaps with Phluence's patient services and market access solutions but as part of a much broader portfolio.
• Medidata (Dassault Systèmes): Medidata offers clinical and commercial platforms for life sciences, including patient engagement capabilities. It is a broader incumbent that intersects with Phluence's market access and patient journey solutions.

Others

• ZS Associates: ZS is a major consulting and technology firm serving pharmaceutical commercialization, including patient services and market access strategy. It is an adjacent enabler that often partners with or competes against platforms like Phluence.
• Deloitte (Pharma & Life Sciences practice): Deloitte's pharma and life sciences practice delivers patient services, market access, and commercialization consulting — an adjacent service provider that competes for the same enterprise budget as Phluence.

Emerging players

• PatientPoint: PatientPoint provides digital patient engagement at the point of care, with overlap to Phluence's patient engagement and adherence use cases but a narrower channel focus (in-office touchpoints).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lifelinkhealth
• LinkedInlinkedin.com/company/lifelink-inc--

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles17 records

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phluence